Guest: Edward S. Kim, MD

Obtaining a tissue biopsy has always been the standard for reaching both early and late-stage non-small cell lung cancer (NSCLC) diagnoses, but that’s no longer the case for all stages. See for yourself how the paradigm has changed with Dr. Edward Kim, Chair of Solid Tumor Oncology and Investigational Therapeutics at Levine Cancer Institute.

Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.